In addition, TEAD2 (TEA domain transcription factor 2), a ferroptosis regulator, is demonstrated to function as novel prognostic target for the prediction of HCC outcome, and is associated with infiltrating immune cells including macrophages, neutrophils, and lymphocytes (Ren et al., 2022). Here, TEAD2 is linked to hepatocellular carcinoma.